Changes in the Central Dopaminergic Systems in the Streptozotocin-induced Diabetic Rats

Overview

Journal Arch Pharm Res

Specialty Pharmacology

Date 1994 Dec 1

PMID 10319147

Citations 11

Authors

D K Lim

K M Lee

I K Ho

Affiliations

Soon will be listed here.

Abstract

The behavioral response, dopamine metabolism, and characteristics of dopamine subtypes after developing the hyperglycemia were studied in the striata of rats. In animals developed hyperglycemia, the on-set and duration of cataleptic behavior responded to SCH 23390 injection was delayed and shortened, respectively. However, the cataleptic responses to spiperone occurred significantly earlier in on-set and prolonged in duration. Dopamine metabolites, dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), were significantly reduced in the striata of hyperglycemic rats. However, level of DA was significantly increased. It is noted that the ratios of DOPAC and HVA to DA were decreased, suggesting decreased turnover of DA. The affinity of striatal D-1 receptors was significantly increased without changes in the number of binding sites, while the maximum binding number of D-2 receptors was significantly increased without affecting its affinity in the diabetic rats. These results indicate that the dopaminergic activity in the striata was altered in hyperglycemic rats. Furthermore, it suggests that the upregulation of dopamine receptors might be due to the decreased dopamine metabolism.

Citing Articles

Atypical Imaging Findings of Nonketotic Hyperglycemic Hemichorea: A Case Report and Review of the Literature.

Stevens C, Malone K, Degueure A, Aldine A, Arevalo O Cureus. 2023; 15(1):e34269.

PMID: 36855488 PMC: 9968442. DOI: 10.7759/cureus.34269.

Differential change in cortical and hippocampal monoamines, and behavioral patterns in streptozotocin-induced type 1 diabetic rats.

Lin L, Tsai F, Yang W, Lai S, Shih C, Lee S Iran J Basic Med Sci. 2018; 21(10):1026-1034.

PMID: 30524676 PMC: 6281071. DOI: 10.22038/IJBMS.2018.29810.7197.

Reduced insulin-receptor mediated modulation of striatal dopamine release by basal insulin as a possible contributing factor to hyperdopaminergia in schizophrenia.

Caravaggio F, Hahn M, Nakajima S, Gerretsen P, Remington G, Graff-Guerrero A Med Hypotheses. 2015; 85(4):391-6.

PMID: 26118462 PMC: 5323257. DOI: 10.1016/j.mehy.2015.06.011.

Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humans.

Caravaggio F, Borlido C, Hahn M, Feng Z, Fervaha G, Gerretsen P Int J Neuropsychopharmacol. 2015; 18(7):pyv014.

PMID: 25716779 PMC: 4540108. DOI: 10.1093/ijnp/pyv014.

Chorea-ballism associated with ketotic hyperglycemia.

Chen C, Zheng H, Yang L, Hu Z Neurol Sci. 2014; 35(12):1851-5.

PMID: 25262066 DOI: 10.1007/s10072-014-1968-1.

References

Zukin S, Young A, Snyder S . Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc Natl Acad Sci U S A. 1974; 71(12):4802-7. PMC: 433985. DOI: 10.1073/pnas.71.12.4802. View

Costall B, Naylor R . Neuroleptic and non-neuroleptic catalepsy. Arzneimittelforschung. 1973; 23(5):674-83. View

Carboni E, Memo M, Tanda G, Carruba M, Spano P . Effect of temperature and ionic environment on the specific binding of (3)H(-)sulpiride to membranes from different rat brain regions. Neurochem Int. 2010; 7(2):279-84. DOI: 10.1016/0197-0186(85)90116-0. View

Watkins 3rd J, Sherman S . Long-term diabetes alters the hepatobiliary clearance of acetaminophen, bilirubin and digoxin. J Pharmacol Exp Ther. 1992; 260(3):1337-43. View

Mayer G, Shoup R . Simultaneous multiple electrode liquid chromatographic-electrochemical assay for catecholamines, indole-amines and metabolites in brain tissue. J Chromatogr. 1983; 255:533-44. DOI: 10.1016/s0021-9673(01)88308-4. View

Saller C . Dopaminergic activity is reduced in diabetic rats. Neurosci Lett. 1984; 49(3):301-6. DOI: 10.1016/0304-3940(84)90306-9. View

Dunstan R, Broekkamp C, Lloyd K . Involvement of caudate nucleus, amygdala or reticular formation in neuroleptic and narcotic catalepsy. Pharmacol Biochem Behav. 1981; 14(2):169-74. DOI: 10.1016/0091-3057(81)90239-2. View

Salkovic M, Lackovic Z . Brain D1 dopamine receptor in alloxan-induced diabetes. Diabetes. 1992; 41(9):1119-21. DOI: 10.2337/diab.41.9.1119. View

Meller E, Kuga S, Friedhoff A, Goldstein M . Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist. Life Sci. 1985; 36(19):1857-64. DOI: 10.1016/0024-3205(85)90159-6. View

10.

Stoof J, Kebabian J . Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 1984; 35(23):2281-96. DOI: 10.1016/0024-3205(84)90519-8. View

11.

Saller C, Chiodo L . Glucose suppresses basal firing and haloperidol-induced increases in the firing rate of central dopaminergic neurons. Science. 1980; 210(4475):1269-71. DOI: 10.1126/science.6254155. View

12.

Westerink B, Korf J . Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain. Eur J Pharmacol. 1976; 37(2):249-55. DOI: 10.1016/0014-2999(76)90032-7. View

13.

Carrier G, Aronstam R . Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes. J Pharmacol Exp Ther. 1990; 254(2):445-9. View

14.

Porceddu M, Giorgi O, Ongini E, Mele S, Biggio G . 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine. Life Sci. 1986; 39(4):321-8. DOI: 10.1016/0024-3205(86)90650-8. View

15.

Barone P, Tucci I, Parashos S, Chase T . Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade. Eur J Pharmacol. 1988; 149(3):225-32. DOI: 10.1016/0014-2999(88)90652-8. View

16.

Lozovsky D, Saller C, Kopin I . Dopamine receptor binding is increased in diabetic rats. Science. 1981; 214(4524):1031-3. DOI: 10.1126/science.6458088. View

17.

Consolo S, Girotti P, Russi G, Di Chiara G . Endogenous dopamine facilitates striatal in vivo acetylcholine release by acting on D1 receptors localized in the striatum. J Neurochem. 1992; 59(4):1555-7. DOI: 10.1111/j.1471-4159.1992.tb08473.x. View

18.

Erny R, Berezo M, Perlman R . Activation of tyrosine 3-monooxygenase in pheochromocytoma cells by adenosine. J Biol Chem. 1981; 256(3):1335-9. View

19.

CHU P, Lin M, Shian L, Leu S . Alterations in physiologic functions and in brain monoamine content in streptozocin-diabetic rats. Diabetes. 1986; 35(4):481-5. DOI: 10.2337/diab.35.4.481. View

20.

Hoskins B, Scott J . Evidence for a direct action of insulin to increase renal reabsorption of calcium and for an irreversible defect in renal ability to conserve calcium due to prolonged absence of insulin. Diabetes. 1984; 33(10):991-4. DOI: 10.2337/diab.33.10.991. View